Russia Comedy wellness stage love Career show audience Russia

Rhod Gilbert reflects on “positive” cancer experience: “I am gorging on life”

Reading now: 328
www.nme.com

diagnosed with stage four head and neck cancer back in July 2022, before undergoing a year of successful treatment.In his new stand-up show, Rhod Gilbert And The Giant Grapefruit, which is currently touring, the comedian speaks about his experience of finding the cancerous lump and the journey that came after – it has also been the subject of a Channel 4 documentary, A Pain In The Neck.Speaking to The Times, he said he ends his shows by explaining that his cancer experience has left him “gorging on life”.“In the end I thought I’d say, ‘I’m not sorry that I got cancer.’” he said. “I feel guilty saying this because of what my wife has been through — we just lost her dad to cancer as well, so it’s been a living hell for her.

But for me it is a positive thing. That doesn’t mean I want it back. But I am just gorging on life.”Gilbert lost two and a half stone in the year he suffered from the disease, and although he has recovered, he is still required to have regular medical check-ups every eight weeks, with his chances of a relapse apparently being like “Russian roulette”.“I have hated the sound of the alarm clock my entire life.

Now I go, ‘Hooray, here comes another day.’” he said.“I’ve got it to thank for where I’ve got to in my career. It’s still early days for me.

But I think I’m a different person. I’m still anxious and all the things you’ve seen from me on stage. But everything has suddenly clicked into shape.

Read more on nme.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

Susan Hopkins - COVID-19 variants identified in the UK – latest updates - gov.uk - Britain - city Oxford
gov.uk
52%
753
COVID-19 variants identified in the UK – latest updates
UKHSA) has published its containing updated analysis of the emergent variant BA.2.86.BA.2.86 continues to transmit within the UK, with sporadic cases identified in most regions.The briefing contains early laboratory data from a number of scientific organisations around the UK, including UKHSA’s own Vaccine Development and Evaluation Centre (VDEC), the University of Oxford, the Glasgow Centre of Virus Research and the Pirbright Institute.This early data indicates that BA.2.86 is no more likely to evade existing antibodies than XBB.1.5, another variant that has been circulating widely in the UK.While the available data remains limited, there is currently no evidence to suggest that BA.2.86 infection is more likely to make people seriously ill than currently-circulating variants, while vaccination is likely to provide continued protection.UKHSA will continue to monitor vaccine effectiveness in the population throughout the winter and will publish updated analysis in due course.Professor Susan Hopkins, Chief Medical Advisor, UKHSA said:While this is still very early data and more research is needed before we can be certain, it is encouraging to see an initial indication that BA.2.86 demonstrates similar levels of antibody escape compared to other variants circulating in the UK. The available data is too limited to draw conclusions about the severity of the illness it causes, but there is so far no evidence to suggest that it is more likely to make people seriously ill than other Omicron variants in circulation.The autumn vaccination programme started this month, and this new data shows once again how important it is that the most vulnerable among us are fully vaccinated in order to receive the greatest possible protection.
DMCA